Individualized Medication Guidance for Breast Cancer
This test detects 348 genes, including HRR pathway genes. The content involves targeted breast cancer therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients.
Features of Individualized Breast Cancer Medication
Applicable Population of Individualized Medication Guidance for Breast Cancer
Late-stage newly diagnosed breast cancer patients who need targeted therapy and immunotherapy.
Patients with relapsed, drug-resistant breast cancer.
Breast cancer patients who need targeted therapy and immunotherapy through liquid biopsy.
If you want to know more details of breast cancer diagnosisand breast cancer genetic test, please visit our website.
CapitalBio Technology Co, Ltd. is the industrialized platform of CapitalBioCorporation and Biochip Beijing National Engineering Research Center and one of the core enterprises of Tsinghua University in the field of life and health. CapitalBio Technology was registered and established in August 2012 and had production, R&D bases and marketing operation centers for biochips, instrument and equipment in Beijing, Shanghai, Chongqing, Chengdu, Dongguan, Hong Kong (China) and San Diego and other places, with a total office area of over 150,000 ㎡ and employees of over 2,000 persons.
We can also offer sorts of life sciences instrumentsfor sale, if you have needs, please contact us.
在线联系供应商
Other supplier products
 |
CapitalBio® Isothermal Nucleic Acid Amplification Microfluidic Chip Analyzer RTisochip™-A | CapitalBio® Isothermal Nucleic Acid Amplification Microfluidic Chip Analyzer RTisochip™-A and the supporting dish chip are a new platform... |
 |
Karyotype Analysis | The morphological structure and number of chromosomes of the cells to be tested are analyzed to determine whether their karyotype is consistent wit... |
 |
Individualized Medication Guidance for Prostate Cancer | This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk as... |
![Genetic Testing for BRCA1/2 Targeted-drug Guidance [ Germline + Somatic]](/images/products/products_918645_3ed639acb6109822155d13588d134efd.jpeg) |
Genetic Testing for BRCA1/2 Targeted-drug Guidance [ Germline + Somatic] | This germline testingdetects somatic and germline SNV, InDel and CNV mutations in the BRCA1 and BRCA2 genes, covering the entire coding region of t... |
 |
CNV-seq Detection (Semiconductor Sequencing) | The detection kit, which is based on the BES 4000 platform, is used to perform low-depth whole-genome sequencing of DNA. The sequencing results are... |
